bistaishor(@Square-Creator-534233669)'s insights

Post

--Bullish

Big shift in US marijuana policy! DOJ just moved state-regulated medical marijuana & FDA-approved products from Schedule I (like heroin) to Schedule III — recognizing lower abuse potential.This could reshape the $47B industry without full federal legalization.
Cannabis stocks reacted fast.Trump admin delivering on medical access promises. What’s next?
#Marijuana #CannabisPolicy $USDC 

Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content. See T&Cs.

USDC+0.02%

.css-1iqe90x{box-sizing:border-box;margin:0;min-width:0;color:#EAECEF;}Big shift in US marijuana policy! DOJ just moved state-regulated medical marijuana & FDA-approved products from Schedule I (like heroin) to Schedule III — recognizing lower abuse potential.

Big shift in US marijuana policy! DOJ just moved state-regulated medical marijuana & FDA-approved products from Schedule I (like heroin) to Schedule III — recognizing lower abuse potential.